在接受达比加群治疗的中风患者中，使用重组组织型纤溶酶原激活剂后发生致命性脑出血。 - Suppr

Fatal intracerebral hemorrhage associated with administration of recombinant tissue plasminogen activator in a stroke patient on treatment with dabigatran.

作者信息

Casado Naranjo Ignacio, Portilla-Cuenca Juan Carlos, Jiménez Caballero Pedro Enrique, Calle Escobar Maria Luisa, Romero Sevilla Raúl Mauricio

机构信息

Department of Neurology, Stroke Unit, Hospital San Pedro de Alcántara, Cáceres, Spain.

出版信息

Cerebrovasc Dis. 2011;32(6):614-5. doi: 10.1159/000334578. Epub 2011 Dec 1.

DOI:10.1159/000334578

PMID:22133608

Abstract

摘要

相似文献

Fatal intracerebral hemorrhage associated with administration of recombinant tissue plasminogen activator in a stroke patient on treatment with dabigatran.在接受达比加群治疗的中风患者中，使用重组组织型纤溶酶原激活剂后发生致命性脑出血。

Cerebrovasc Dis. 2011;32(6):614-5. doi: 10.1159/000334578. Epub 2011 Dec 1.

Fibrinolytic treatment of acute ischemic stroke for patients on new oral anticoagulant drugs.新型口服抗凝药物治疗的急性缺血性脑卒中患者的纤维蛋白溶解治疗

Cerebrovasc Dis. 2011;32(6):616-9. doi: 10.1159/000334579. Epub 2011 Dec 1.

Acute ischemic stroke treated with intravenous tissue plasminogen activator in a patient taking dabigatran with radiographic evidence of recanalization.接受达比加群治疗的患者发生急性缺血性脑卒中，给予静脉组织型纤溶酶原激活物治疗，影像学显示再通。

J Stroke Cerebrovasc Dis. 2012 Nov;21(8):917.e5-8. doi: 10.1016/j.jstrokecerebrovasdis.2012.05.003. Epub 2012 Jun 9.

Good outcome after intravenous thrombolysis for acute stroke in a patient under treatment with dabigatran.在接受达比加群治疗的患者中，静脉溶栓治疗急性卒中后预后良好。

Am J Emerg Med. 2014 Nov;32(11):1435.e1-2. doi: 10.1016/j.ajem.2014.04.021. Epub 2014 Apr 18.

J Stroke Cerebrovasc Dis. 2014 Feb;23(2):e133-4. doi: 10.1016/j.jstrokecerebrovasdis.2013.08.011. Epub 2013 Oct 6.

Intravenous tissue plasminogen activator treatment for ischemic stroke in dabigatran-treated patients.达比加群治疗的患者中静脉注射组织型纤溶酶原激活剂治疗缺血性卒中

Acta Neurochir (Wien). 2012 Jan;154(1):87. doi: 10.1007/s00701-011-1196-x. Epub 2011 Oct 25.

Dabigatran compared with warfarin for stroke prevention in atrial fibrillation.达比加群与华法林在心房颤动卒中预防中的比较。

Ann Intern Med. 2011 Apr 19;154(8):570; author reply 570-1. doi: 10.7326/0003-4819-154-8-201104190-00013.

Dabigatran for stroke prevention in all patients with atrial fibrillation?达比加群用于所有房颤患者的卒中预防？

Pharmacotherapy. 2011 Aug;31(8):725-8. doi: 10.1592/phco.31.8.725.

Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion.达比加群酯与华法林在心房颤动患者中的比较：一项关于接受心脏转复术患者的分析。

Circulation. 2011 Jan 18;123(2):131-6. doi: 10.1161/CIRCULATIONAHA.110.977546. Epub 2011 Jan 3.

[Pharmacological sheet. Dabigatran, oral administration (Pradaxa)].[药理说明书。达比加群，口服给药（Pradaxa）]

J Pharm Belg. 2012 Mar(1):37-8.

引用本文的文献

Before, during, and after: An Argument for Safety and Improved Outcome of Thrombolysis in Acute Ischemic Stroke with Direct Oral Anticoagulant Treatment.在急性缺血性脑卒中直接口服抗凝治疗中：溶栓治疗的安全性和预后改善的论证——从开始到结束。

Ann Neurol. 2024 Nov;96(5):871-886. doi: 10.1002/ana.27058. Epub 2024 Sep 11.

Repurposing FDA Approved Drugs as JNK3 Inhibitor for Prevention of Neuroinflammation Induced by MCAO in Rats.将美国食品药品监督管理局（FDA）批准的药物重新用作JNK3抑制剂，以预防大鼠大脑中动脉闭塞（MCAO）诱导的神经炎症。

J Inflamm Res. 2020 Dec 24;13:1185-1205. doi: 10.2147/JIR.S284471. eCollection 2020.

Management of Patients on Non-Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association.急性护理和围手术期非维生素K拮抗剂口服抗凝剂治疗患者的管理：美国心脏协会科学声明

Circulation. 2017 Mar 7;135(10):e604-e633. doi: 10.1161/CIR.0000000000000477. Epub 2017 Feb 6.

Approach to the new oral anticoagulants in family practice: part 2: addressing frequently asked questions.家庭医疗中新型口服抗凝剂的应用：第2部分：解答常见问题

Can Fam Physician. 2014 Nov;60(11):997-1001.

Is intravenous recombinant tissue plasminogen activator (r-tPA) safe in patients on Dabigatran?在服用达比加群的患者中，静脉注射重组组织型纤溶酶原激活剂（r-tPA）是否安全？

J Vasc Interv Neurol. 2014 May;7(1):21-2.

Intravenous thrombolysis in a stroke patient receiving rivaroxaban.

Cerebrovasc Dis Extra. 2013 Oct 26;3(1):153-5. doi: 10.1159/000355839. eCollection 2013.

Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban.新型直接口服抗凝剂（DOACs），即阿哌沙班、达比加群和利伐沙班相关并发症的紧急处理建议。

Clin Res Cardiol. 2013 Jun;102(6):399-412. doi: 10.1007/s00392-013-0560-7. Epub 2013 May 14.

Thrombolysis in a stroke patient on dabigatran anticoagulation: case report and synopsis of published cases.达比加群抗凝治疗的中风患者的溶栓治疗：病例报告及已发表病例综述

Case Rep Neurol. 2013 Mar 25;5(1):56-61. doi: 10.1159/000350570. Print 2013 Jan.

Renal function estimations and dose recommendations for dabigatran, gabapentin and valaciclovir: a data simulation study focused on the elderly.达比加群、加巴喷丁和伐昔洛韦的肾功能估计和剂量推荐：一项针对老年人的数据分析模拟研究。

BMJ Open. 2013 Apr 11;3(4). doi: 10.1136/bmjopen-2013-002686. Print 2013.

Thrombolysis in ischemic stroke patients on treatment with Dabigatran.达比加群治疗的缺血性中风患者的溶栓治疗

Intern Emerg Med. 2013 Aug;8(5):451-2. doi: 10.1007/s11739-013-0907-0. Epub 2013 Feb 7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Fatal intracerebral hemorrhage associated with administration of recombinant tissue plasminogen activator in a stroke patient on treatment with dabigatran.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献